Cidara Therapeutics Inc. (NASDAQ: CDTX)
$12.82
+0.3200 ( +2.56% ) 25.9K
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Market Data
Open
$12.82
Previous close
$12.50
Volume
25.9K
Market cap
$59.03M
Day range
$12.18 - $13.06
52 week range
$10.00 - $24.40
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 110 | Apr 22, 2024 |
8-k | 8K-related | 13 | Apr 16, 2024 |
8-k | 8K-related | 13 | Apr 05, 2024 |
nt | Quarterly Reports | 1 | Apr 01, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 12, 2024 |